Showing 39,881 - 39,900 results of 100,619 for search '(( 5 point decrease ) OR ( 5 ((((a decrease) OR (mean decrease))) OR (nn decrease)) ))', query time: 1.36s Refine Results
  1. 39881

    Configuration of the experimental environment. by Yulu Zhang (1774471)

    Published 2023
    “…According to the experimental results, the recognition accuracy rate of the improved model is 95.2%, with a model size of 7.9M. Compared with YOLOv7, the GFLOPs are reduced by 54.5%, the model size is compressed by 37.8%, and the accuracy is improved by 4.9%. …”
  2. 39882

    Results of ablation experiments. by Yulu Zhang (1774471)

    Published 2023
    “…According to the experimental results, the recognition accuracy rate of the improved model is 95.2%, with a model size of 7.9M. Compared with YOLOv7, the GFLOPs are reduced by 54.5%, the model size is compressed by 37.8%, and the accuracy is improved by 4.9%. …”
  3. 39883

    Performance comparison with other models. by Yulu Zhang (1774471)

    Published 2023
    “…According to the experimental results, the recognition accuracy rate of the improved model is 95.2%, with a model size of 7.9M. Compared with YOLOv7, the GFLOPs are reduced by 54.5%, the model size is compressed by 37.8%, and the accuracy is improved by 4.9%. …”
  4. 39884

    Comparison of different methods. by Yulu Zhang (1774471)

    Published 2023
    “…According to the experimental results, the recognition accuracy rate of the improved model is 95.2%, with a model size of 7.9M. Compared with YOLOv7, the GFLOPs are reduced by 54.5%, the model size is compressed by 37.8%, and the accuracy is improved by 4.9%. …”
  5. 39885

    Table_1_Knowledge and Response to Stroke Among Lebanese Adults: A Population-Based Survey.DOCX by Sylvia Saade (12749600)

    Published 2022
    “…Multivariable linear regression models were conducted to examine socio-demographic, social habits, and clinical factors independently associated with the SKT and the STAT scores.</p>Results<p>The mean SKT score of the participants was 9.16. 48.5% showed a poor stroke-related knowledge level and 51.5% a good knowledge level. …”
  6. 39886

    Hypoxia-inducible factor-1 alpha as a therapeutic target for primary effusion lymphoma by Prabha Shrestha (776391)

    Published 2017
    “…Moreover, HIF-1α knockdown led to a decrease in the expression of various KSHV latent genes, including LANA, vCyclin, kaposin, and miRNAs, under both normoxic and hypoxic conditions. …”
  7. 39887
  8. 39888
  9. 39889
  10. 39890
  11. 39891
  12. 39892
  13. 39893
  14. 39894
  15. 39895
  16. 39896
  17. 39897

    Figure 2 from PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma by Khaled Mohamed Nassar (19810317)

    Published 2025
    “…<p><i>PELP1</i>-KD/SMIP34 treatment decreased cell viability, clonogenicity, and invasiveness of HCC cells. …”
  18. 39898

    Image_1_Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibr... by Kátia Nunes da Silva (11716274)

    Published 2021
    “…<p>Background: The patients with coronavirus disease 2019 (COVID-19) associated with severe acute respiratory distress syndrome (ARDS) may require prolonged mechanical ventilation which often results in lung fibrosis, thus worsening the prognosis and increasing fatality rates. A mesenchymal stromal cell (MSC) therapy may decrease lung inflammation and accelerate recovery in COVID-19. …”
  19. 39899

    Table_1_Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibr... by Kátia Nunes da Silva (11716274)

    Published 2021
    “…<p>Background: The patients with coronavirus disease 2019 (COVID-19) associated with severe acute respiratory distress syndrome (ARDS) may require prolonged mechanical ventilation which often results in lung fibrosis, thus worsening the prognosis and increasing fatality rates. A mesenchymal stromal cell (MSC) therapy may decrease lung inflammation and accelerate recovery in COVID-19. …”
  20. 39900

    Image_3_Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibr... by Kátia Nunes da Silva (11716274)

    Published 2021
    “…<p>Background: The patients with coronavirus disease 2019 (COVID-19) associated with severe acute respiratory distress syndrome (ARDS) may require prolonged mechanical ventilation which often results in lung fibrosis, thus worsening the prognosis and increasing fatality rates. A mesenchymal stromal cell (MSC) therapy may decrease lung inflammation and accelerate recovery in COVID-19. …”